Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

More Ranitidine Products, Altaire Eye Drops Among Recent OTC Recalls

Dec 10 2019

• By Malcolm Spicer

Product Recall - Image

Related Content

Direct Seller's CBD Supplement Recall Mandated, More Ranitidine, Tween Cosmetic Recalls

Nov 15 2019

FDA Finds Ranitidine Poses Little Risk, But Concerns Linger

Nov 04 2019

Testing Ranitidine With Too Much Heat Could Generate NDMA, FDA Says

Oct 02 2019

J&J Starts First Baby Powder Recall Linked To Asbestos Finding

Oct 18 2019

Asbestos In Johnson's Baby Powder May Come From Test Labs, J&J Says

Oct 29 2019

Clear Eyes Recall Adds Clarity To Extent Of Impact From Altaire Sterility Concerns

Aug 28 2019

Additional Topics

United States Recalls OTC Drugs Dietary Supplements Advertising, Marketing & Sales Commercial Companies Compliance FDA Manufacturing Policy Regulation Consumer

More from Recalls

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window